Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
biotech
clinical trials
fda
life sciences
national
national blog main
eli lilly
europe blog main
national top stories
new york blog main
san francisco blog main
san francisco top stories
abaloparatide
abbvie
alder biopharmaceuticals
allergan
biohaven
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cgpr
chronic migraine
david rind
detroit blog main
detroit top stories
episodic migraine
eptinezumab
erenumab
europe top stories
european commission
food and drug administration
fremanezumab
galcanezumab
indiana blog main
indiana top stories
institute for clinical and economic review
merck
What
nod
3
×
amgen
approval
class
developed
drug
fda
medicines
migraine
new
wins
adults
allergan
amgen’s
approved
candidates
carries
europe
european
gets
head
heart
marketing
medicine
monday
osteoporosis
pain
pill
preventive
raise
risk
starts
treat
treatment
ubrelvy
ubrogepant
warning
won
Language
unset
Current search:
amgen
×
nod
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines